SAB Biotherapeutics Inc Cash Flow Reinvestment Rate
SAB Biotherapeutics Inc cash flow reinvestment rate. SAB Biotherapeutics Inc (SABS) has a Cash Flow Reinvestment Rate of 41.94x as of December 2022, reinvesting $9.09 Million (capex $117.75K plus investments $-8.97 Million) from operating cash flow of $216.72K. Explore SAB Biotherapeutics Inc (SABS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of SAB Biotherapeutics Inc (2020–2021)
Cash flow reinvestment rate of SAB Biotherapeutics Inc from 2020 to 2021. Historical reinvestment intensity for SAB Biotherapeutics Inc across 2 annual periods. Explore SABS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
SAB Biotherapeutics Inc Cash Flow Reinvestment Rate by Year (2020–2021)
SAB Biotherapeutics Inc cash flow reinvestment rate by year from 2020 to 2021. Year-by-year capital reinvestment analysis for SAB Biotherapeutics Inc. For the full cash flow conversion analysis, see SABS cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 11.02x | $21.89 Million | $1.99 Million | $10.94 Million | ▲ +333.0% |
| 2020 | 2.54x | $25.45 Million | $10.00 Million | $12.73 Million | — |